These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37873846)

  • 1. A Newborn Screening Program for Sickle Cell Disease in Murcia (Spain).
    Sánchez-Villalobos M; Campos Baños E; Juan Fita MJ; Egea Mellado JM; Gonzalez Gallego I; Beltrán Videla A; Berenguer Piqueras M; Bermúdez Cortés M; Moraleda Jiménez JM; Guillen Navarro E; Salido Fierrez E; Pérez-Oliva AB
    Int J Neonatal Screen; 2023 Oct; 9(4):. PubMed ID: 37873846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sickle cell diseases: What can nuclear medicine offer?
    Niccoli Asabella A; Altini C; Nappi AG; Lavelli V; Ferrari C; Marzullo A; Loiodice A; Rubini G
    Hell J Nucl Med; 2019; 22(1):2-3. PubMed ID: 30843001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
    Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for sickle cell disease in newborns: a systematic review.
    Runkel B; Klüppelholz B; Rummer A; Sieben W; Lampert U; Bollig C; Markes M; Paschen U; Angelescu K
    Syst Rev; 2020 Oct; 9(1):250. PubMed ID: 33126922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country.
    García-Morín M; Bardón-Cancho EJ; Beléndez C; Zamarro R; Béliz-Mendiola C; González-Rivera M; Vecilla C; Llorente-Otones L; Pérez-Alonso V; Román SS; Sebastián E; Dulín E; Cela E
    Ann Hematol; 2020 Jul; 99(7):1465-1474. PubMed ID: 32451712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neonatal screening of hemoglobinopathies and G6PD deficiency in Catalonia (Spain). Molecular study of sickle cell disease associated with alpha thalassemia and G6PD deficiency].
    Mañú Pereira Mdel M; Cabot A; Martínez González A; Sitjà Navarro E; Cararach V; Sabrià J; Boixaderas J; Teixidor R; Bosch A; López Vílchez MA; Martín Ibáñez I; Carrión T; Plaja P; Sánchez M; Vives Corrons JL
    Med Clin (Barc); 2007 Jun; 129(5):161-4. PubMed ID: 17669331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
    Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crizanlizumab in sickle cell disease.
    Kaur K; Kennedy K; Liles D
    Pain Manag; 2023 Oct; ():. PubMed ID: 37850353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle Cell Disease: A Review.
    Kavanagh PL; Fasipe TA; Wun T
    JAMA; 2022 Jul; 328(1):57-68. PubMed ID: 35788790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.
    Russo G; De Franceschi L; Colombatti R; Rigano P; Perrotta S; Voi V; Palazzi G; Fidone C; Quota A; Graziadei G; Pietrangelo A; Pinto V; Ruffo GB; Sorrentino F; Venturelli D; Casale M; Ferrara F; Sainati L; Cappellini MD; Piga A; Maggio A; Forni GL
    Orphanet J Rare Dis; 2019 May; 14(1):120. PubMed ID: 31146777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neonatal screening of sickle cell disease in the Balearic Islands Autonomous Community. Pilot study in anonymous unrelated population].
    López-Escribano H; Vila Vidal M; Barceló Bennassar A; Riesco Prieto M; Ayllón Gatnau O
    An Pediatr (Barc); 2009 May; 70(5):429-33. PubMed ID: 19376755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effect of the spleen in sickle cell patients. A comparative study between patients with asplenia/hyposplenism and hypersplenism.
    Peretz S; Livshits L; Pretorius E; Makhro A; Bogdanova A; Gassmann M; Koren A; Levin C
    Front Physiol; 2022; 13():796837. PubMed ID: 36105295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the public health impact of voxelotor in the management of sickle cell disease in France.
    Galacteros F; Ethgen O; Beillat M
    PLoS One; 2023; 18(9):e0291211. PubMed ID: 37703228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of sickle cell disease and other hemoglobin variants in 10,095 Lebanese neonates.
    Khoriaty E; Halaby R; Berro M; Sweid A; Abbas HA; Inati A
    PLoS One; 2014; 9(9):e105109. PubMed ID: 25180595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curative Therapies for Sickle Cell Disease.
    Kaviany S; Barnawi Z; LaBelle J
    Pediatr Ann; 2024 Feb; 53(2):e56-e61. PubMed ID: 38302122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
    Nader E; Romana M; Connes P
    Front Immunol; 2020; 11():454. PubMed ID: 32231672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal haemoglobinopathy screening in Spain.
    Mañú Pereira M; Corrons JL
    J Clin Pathol; 2009 Jan; 62(1):22-5. PubMed ID: 19103853
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.